EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions

Suzanne M Selvaggi iD

Diagnostic Cytopathology · 2026-09 · 54 (9) · 631-636

DOI: 10.1002/dc.70147 ↗

At a glance

Journal article in Diagnostic Cytopathology, published online on 2026-05-20. Written by Suzanne M Selvaggi. Institution: Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Major MEDLINE topics: Biomarkers, Tumor, Mesothelioma, Ascitic Fluid, Pleural Effusion, Malignant. 19 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Mesothelioma is a rare tumor that arises from the serosal cells lining the serous cavities, most commonly the pleura followed by the peritoneum. Presenting symptoms include pleuritic pain and bloody effusions that recur. Although cytologic analysis cannot determine the mesothelial subtype or in situ from invasive disease, the application of biomarkers to serous effusions has aided in distinguishing benign from malignant mesothelial cells. This study evaluates the diagnostic value of specialized techniques in the cytologic diagnosis of mesothelioma pre‐ and post‐implementation of biomarkers and a robust immunohistochemical (IHC) panel.

Methods

From January 1, 2013, through December 31, 2025, 26 effusions (20 pleural, six peritoneal) from 16 males and four females (mean, 72 years; median, 75 years) were evaluated and contained atypical mesothelial cells. In each case, ThinPrep slides were made for cytologic analysis and cell blocks were prepared for IHC and biomarker evaluation. Prior to 2017, the IHC markers were limited, whereas after that time, biomarkers including BAP1 and MTAP were available.

Results

Cytologically the effusions were cellular and contained atypical, enlarged mesothelial cells arranged singly and in clusters with a normal nuclear/cytoplasmic ratio. Five effusions (2013–2015) were diagnosed as suspicious for mesothelioma based on the cytologic findings and a limited IHC panel (calretinin, CK 5/6, TTF‐1). The diagnosis was confirmed on biopsy/resection specimens. For 17 effusions (2017–2025), an expanded IHC and biomarker panel aided in the cytologic diagnosis of mesothelioma. Three effusions were from patients with a known history of pulmonary mesothelioma, so IHC stains were not performed. Histologic confirmation was done in 23 cases.

Conclusions

The application of IHC and biomarkers in combination with cytomorphology aids in the diagnosis of mesothelioma on fluid cytology.

Subjects

MeSH terms (MEDLINE)

Biomarkers, TumorMesotheliomaAscitic FluidPleural Effusion, MalignantHumansFemaleMaleImmunohistochemistryAgedMiddle AgedAged, 80 and overMesothelioma, Malignant

Author keywords

BAP1MTAPbiomarkersmesotheliomapleural/peritoneal effusionsspecialized techniques

Substances

Biomarkers, Tumor

Authors and institutions

  • Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

ORCID profiles: Suzanne M Selvaggi

Cite

APA

Selvaggi, S. M. (2026). The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions. Diagnostic Cytopathology, 54(9), 631-636. https://doi.org/10.1002/dc.70147

Vancouver

Selvaggi SM. The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions. Diagnostic Cytopathology. 2026;54(9):631-636. doi:10.1002/dc.70147

BibTeX
@article{Selvaggi2026,
  author = {Selvaggi, Suzanne M},
  title = {The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions},
  journal = {Diagnostic Cytopathology},
  year = {2026},
  volume = {54},
  number = {9},
  pages = {631--636},
  doi = {10.1002/dc.70147}
}
Start for free →